Daymark Health featured prominently this week with a mix of leadership expansion and increased industry visibility. The company announced the hire of Ryan Liefer as VP of Provider Growth, drawing on his experience at Oak Street Health, HCSC, Walgreens Health, Stellar Health, and Sylvan Health to advance value-based care strategies.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Daymark emphasized that Liefer will focus on expanding partnerships with provider groups nationwide and scaling provider relationships across the healthcare continuum. The move underscores an investment in senior leadership aimed at accelerating growth initiatives, deepening penetration into value-based care models, and broadening the firm’s national provider network.
In parallel, Daymark highlighted its cancer care model at the National Healthcare Continuum Conference in Scottsdale, where representatives presented during a Connected Care Briefing session. The company showcased its approach to improving cancer care beyond the clinic, working with providers, payers, and patients to support coordinated, value-based oncology care.
This conference presence is designed to boost visibility among key healthcare stakeholders and decision-makers, potentially paving the way for new commercial partnerships and pilot programs. By emphasizing integrated reimbursement and outcomes-based models, Daymark is aligning itself with areas attracting growing U.S. healthcare investment and policy support.
If the company can demonstrate measurable improvements in cancer care delivery and patient outcomes, this platform could translate into broader adoption of its solutions and support revenue growth over time. Taken together, the leadership hire and conference exposure mark a strategically constructive week for Daymark Health as it builds out both its provider-facing capabilities and its profile in value-based oncology and care coordination.

